Stockchase Opinions

Frank HolmesWalgreen Boots AllianceWBABUYNov 18, 2016

Any change in healthcare will only benefit them. This and CVS-N are two great companies.

$83.27

Stock price when the opinion was issued

$12.05

As of Aug 27, 2025. Market Open.

specialty stores
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

COMMENT

They report Tuesday. He likes their deal in which they go private. Let's see if things have gotten better or if there is buyer's remorse.

SELL

They entered a great deal (Walgreens to be taken private by Sycamore in $10 billion). If you own shares, sell and buy Costco.

RISKY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

It was a good quarter. But it is important to note that one quarter does not make a trend, and there is still lots of work to be done here. It is still in turnaround mode. It still has a massive amount of debt. It is cheap, though, and the quarter might see shorts start to cover a bit. So the trend will likely be 'up' and the worst 'could' be over here. But there remains plenty of risk and we would prefer to see another quarter or two of continued improvement, and even pay more once the turn is indeed fully established and on a firm foothold. Much could still go wrong here. 
Unlock Premium - Try 5i Free

DON'T BUY

It reports Friday.  It needs to do something to help its woes. He suspect the CEO has buyers lined up for parts of the company. Don't bet against the CEO, but don't bet on WBA.

SELL

Many headwinds, too big to overcome. Sell, take the loss.

DON'T BUY

He bought CVS instead. WBA did a big purchase of Boots which they may be regretting. WBA really operates pharmacies, plus a medical business. He prefers CVS for Aetna, their insurance business, pharmacy benefits and a medical business.

DON'T BUY

Avoid, because of poor execution and being in a poor sector. There will be a tax on online delivery services. Too many problems.

COMMENT

It will go down only 9 more points. The new CEO needs to invest AI, cut overhead and increase profit. 

DON'T BUY

Problems. Avoid. Called "value", but continues to move south. Technically, 200-day MA is going lower and stock price is below that. 5x forward PE, but earnings growth is negative.

DON'T BUY

The alliance had all this promise, and just hasn't been able to deliver. He's not brave or smart enough to pick the bottom on a stock like this. He owns Loblaw and, with it, Shopper's Drug Mart.

DON'T BUY

Beware of companies closing stores and calling that successfully. Closing stores is never good. This whole space has been challenged. He had a poor experience holding the peer, CVS. WBA was just kicked out of an index.

DON'T BUY

One of the things he looks at is sustainability of dividends. Are you paying your dividends through free cashflow? Cut dividend. Struggled ever since acquiring Boots in the UK a decade ago, which has crippled the company.

DON'T BUY

Stock's been completely annihilated. It's only in the drugstore chain business, which has been really tough.

WATCH
One of the five worst performers in Q1

Down 17% in Q1, plus another 10% today. The CEO though could turn things around in a year. No hurry to buy this one.

DON'T BUY

Wait another quarter to see what the CEO will do. Don't jump the gun. It's a troubled company.